Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) Short Interest Update

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) saw a large decrease in short interest during the month of November. As of November 15th, there was short interest totalling 429,000 shares, a decrease of 74.5% from the October 31st total of 1,680,000 shares. Approximately 2.0% of the shares of the stock are sold short. Based on an average trading volume of 2,950,000 shares, the short-interest ratio is presently 0.1 days.

Cardio Diagnostics Stock Down 3.2 %

Shares of CDIO stock traded down $0.01 during trading hours on Thursday, reaching $0.30. 1,413,718 shares of the stock traded hands, compared to its average volume of 1,319,485. The business has a fifty day moving average price of $0.26 and a 200 day moving average price of $0.43. Cardio Diagnostics has a 1-year low of $0.19 and a 1-year high of $3.56.

Analyst Ratings Changes

Separately, Benchmark restated a “speculative buy” rating and issued a $2.00 target price on shares of Cardio Diagnostics in a report on Tuesday, August 27th.

About Cardio Diagnostics

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.